The Board of Aurobindo Pharma at its meeting held on 01 October 2021 has approved the appointment of S. Damodharan as Chief Operating Officer (COO) for the API vertical. The Board also approved the appointment P. Yugandhar as the Chief Executive Officer
(CEO) of Eugia Pharma Specialities, a wholly owned subsidiary of the Company focused on generic injectables and oncology business.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
